Oestroperos en es it fr

Oestroperos Brand names, Oestroperos Analogs

Oestroperos Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Oestroperos Chemical_Formula

C18H22O2

Oestroperos RX_link

No information avaliable

Oestroperos fda sheet

Oestroperos msds (material safety sheet)

Oestroperos MSDS

Oestroperos Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Oestroperos Molecular Weight

270.366 g/mol

Oestroperos Melting Point

254.5-256 oC

Oestroperos H2O Solubility

3 g/100mL

Oestroperos State

Solid

Oestroperos LogP

4.067

Oestroperos Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Oestroperos Indication

For management of Menopausal and postmenopausal disorders

Oestroperos Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Oestroperos Absorption

43%

Oestroperos side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Oestroperos Patient Information

Oestroperos Organisms Affected

Humans and other mammals